Jubilant Pharmova's Strong Performance Highlights Resilience in Pharmaceuticals Sector

Jubilant Pharmova has shown significant activity today, gaining 5.04% on July 30, 2025. The stock outperformed its sector by 4.5%, reflecting a strong performance in the pharmaceuticals and biotechnology industry. It reached an intraday high of Rs 1220, marking a 5.36% increase during the trading session.
In terms of moving averages, Jubilant Pharmova is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement. Over the past week, the stock has risen by 1.62%, contrasting with the Sensex, which has declined by 1.37%.

Looking at longer-term performance, Jubilant Pharmova has delivered a remarkable 35.41% increase over the last three months and an impressive 65.04% rise over the past year. Year-to-date, the stock has gained 9.86%, outperforming the Sensex's 4.42% increase. Over the last three years, Jubilant Pharmova has surged by 235.82%, significantly outpacing the Sensex's 41.73% growth during the same period.